Key result
Central blood pressure and arterial stiffness measures may serve as informative, noninvasive markers for stratifying the risk of chronic kidney disease progression.
Why the study?
Are measurements of central arterial pressure informative for predicting chronic kidney disease progression?
Are measurements of central arterial pressure informative for predicting chronic kidney disease progression?
Answers are grounded in this paper and cite their sources.
This review highlights the potential utility of central blood pressure and arterial stiffness measurements as noninvasive markers to stratify the risk of chronic kidney disease progression.
Hypertension, diabetes, and proteinuria are well-recognized risk factors for progressive kidney function loss. However, despite excellent antihypertensive and antidiabetic drug therapies, which also often lower urinary protein excretion, there remains a significant reservoir of patients with chronic kidney disease who are at high risk for progression to end-stage kidney disease. This has led to the search for less traditional cardiovascular risk factors that will help stratify patients at risk for more rapid kidney disease progression. Among these are noninvasive estimates of vascular structure and function. Arterial stiffness, manifested by the pulse wave velocity in the aorta, has been established in a number of studies as a significant risk factor for kidney disease progression and cardiovascular endpoints. Much less well studied in chronic kidney disease are measures of central arterial pressures. In this paper we cover the physiology behind the generation of the central pulse wave contour and the studies available using these approaches and conclude with some speculations on the rationale for why measurements of central pressure may be informative for the study of chronic kidney disease progression.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2011) conducted a review in Chronic Kidney Disease. Central blood pressure measurement was evaluated on Chronic kidney disease progression. Central blood pressure and arterial stiffness measures may serve as informative, noninvasive markers for stratifying the risk of chronic kidney disease progression.
Synapse has enriched 10 related papers. Consider them for comparative context: